doi:10.1016/j.virs.2023.11.006

[1]
Kai Lin, 2010: Development of Novel Antiviral Therapies for Hepatitis C Virus, Virologica Sinica, 25, 246-266. doi: 10.1007/s12250-010-3140-2
[2]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B^*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
[3]
Deyin Guo, 2020: Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases, Virologica Sinica, 35, 253-255. doi: 10.1007/s12250-020-00204-7
[4]
Jing Li, Yangyang Hu, Yifei Yuan, Yinan Zhao, Qiqi Han, Canyu Liu, Xue Hu, Yuan Zhou, Yun Wang, Yu Guo, Chunchen Wu, Xinwen Chen, Rongjuan Pei, 2021: Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion, Virologica Sinica, 36, 501-509. doi: 10.1007/s12250-020-00306-2
[5]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research^*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
[6]
Ke Lan, Min-Hua Luo, 2017: Herpesviruses: epidemiology, pathogenesis, and interventions, Virologica Sinica, 32, 347-348. doi: 10.1007/s12250-017-4108-2
[7]
Jaemoo Kim, Jihyun Yang, Young Bong Kim, Hee-Jung Lee, Sehyun Kim, Haryoung Poo, 2019: Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis, Virologica Sinica, 34, 563-571. doi: 10.1007/s12250-019-00135-y
[8]
张玲霞, 王慧芬, 李克, 仲伯华, 刘洪, 盼勇, 1995: Experimental Studises Oil Viral Hepatitis Receptor——targeted Drug L——HSA-AraAMP, Virologica Sinica, 10, 283-.
[9]
孟忠吉, 李磊, 李新宇, 张正茂, 张振华, 田拥军, 王宝菊, 张珺, 雷延昌, 杨东亮, 2005: Development of a Mouse Model of Acute Hepatitis B Virus Infection, Virologica Sinica, 20, 565-569.
[10]
Gui-feng WANG, Li-ping SHI, Jian-ping ZUO, 2008: Anti-Hepatitis B Virus Drugs in Clinical and Preclinical Development, Virologica Sinica, 23, 137-145. doi: 10.1007/s12250-008-2945-8
[11]
殷书荣, 刘玉堂, 田辛, 鲍作义, 蒋豫图, 张习坦, 1992: Preliminary Report of Cell Culture of Hepatitis E Virus, Virologica Sinica, 7, 134-.
[12]
戚中田, 潘卫, 崔大敷, 俞超, 崔恒冉, 1995: Selection, synthesis and application of hepatitis E virus peptides, Virologica Sinica, 10, 290-.
[13]
吕冬梅, 陈尔佳, 谢天宏, 庄俊英, 刘勇, 李春宏, 孙茂盛, 戴长柏, 2001: DNA Immunization of Hepatitis E Virus(HEV), Virologica Sinica, 16, 131-134.
[14]
李方和, 杨东亮, 赵西平, 喻植群, 汪由坤, 郝连杰, 1996: Hepatitis E virus and hepatitis C virus infection in population of blood donor, Virologica Sinica, 11, 17-.
[15]
Qiang Xie, Zhi-xiang Zhou, Ze-lin Li, Yi Zeng, 2011: Transforming Activity of a Novel Mutant of HPV16 E6E7 Fusion Gene, Virologica Sinica, 26, 206-213. doi: 10.1007/s12250-011-3178-9
[16]
Jielin Tang, Muqing Fu, Chonghui Xu, Bao Xue, Anqi Zhou, Sijie Chen, He Zhao, Yuan Zhou, Jizheng Chen, Qi Yang, Xinwen Chen, 2023: Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection, Virologica Sinica, 38, 767-777. doi: 10.1016/j.virs.2023.06.003
[17]
Renfei Lu, Xiuming Wu, Zhenzhou Wan, Yingxue Li, Lulu Zuo, Jianru Qin, Xia Jin, Chiyu Zhang, 2020: Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2, Virologica Sinica, 35, 344-347. doi: 10.1007/s12250-020-00218-1
[18]
范学政, 王琴, 陈振海, 宁宜宝, 王在时, 2005: Expression of Hog Cholera Lapinised Virus E2 Gene in E. coli and the Development of Indirect ELISA with Recombinant Protein, Virologica Sinica, 20, 253-256.
[19]
陈振海, 王琴, 范学政, 宁宜宝, 王在时, 沈青春, 夏春, 2005: Prokaryotic Expression of CSFV E0 Protein and Development of an Indirect ELISA for Detection of Antibody, Virologica Sinica, 20, 135-139.
[20]
Chunchen Wu, Baolin Li, Xiaoyong Zhang, Kaitao Zhao, Yingshan Chen, Yifei Yuan, Yan Liu, Rongjuan Chen, Dongping Xu, Xinwen Chen, Mengji Lu, 2019: Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs, Virologica Sinica, 34, 377-385. doi: 10.1007/s12250-019-00143-y